SVRA Savara Inc

8-K Current Report
Filed: March 13, 2026
Health Care
Pharmaceutical Preparations

Savara Inc (SVRA) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 1.01: Entry into a Material Definitive Agreement

AI Filing Analysis
8-K

Item 1.01 · Entry into a Material Definitive Agreement

  • HQ relocation to Yardley, PA (19 W. College Ave); ~10,795 sq ft leased from ML7 Yardley Partners
  • Lease term July 1, 2026 – Dec 1, 2031 with 5-year renewal option
+3 more insights

Get deeper insights on Savara Inc

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.